This finding provides an experimental and clinical evidence that BDNF is a major element in neuro-inflammation modulation, neuroprotection and neuro-repair in MS disease, which makes the BDNF a promising candidate for new therapeutic strategies in MS. This evidence concerns the gene BDNF and myeloid sarcoma.